- Home
- WHWK vs APYX Comparison
WHWK vs APYX Comparison
Compare WHWK & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- APYX
- Stock Information
- Founded
- WHWK 2007
- APYX 1982
- Country
- WHWK United States
- APYX United States
- Employees
- WHWK N/A
- APYX N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- WHWK Health Care
- APYX Health Care
- Exchange
- WHWK Nasdaq
- APYX Nasdaq
- Market Cap
- WHWK 82.4M
- APYX 85.0M
- IPO Year
- WHWK N/A
- APYX 1987
- Fundamental
- Price
- WHWK $1.82
- APYX $1.96
- Analyst Decision
- WHWK
- APYX Hold
- Analyst Count
- WHWK 0
- APYX 2
- Target Price
- WHWK N/A
- APYX N/A
- AVG Volume (30 Days)
- WHWK 117.1K
- APYX 80.9K
- Earning Date
- WHWK 08-07-2025
- APYX 08-07-2025
- Dividend Yield
- WHWK N/A
- APYX N/A
- EPS Growth
- WHWK N/A
- APYX N/A
- EPS
- WHWK N/A
- APYX N/A
- Revenue
- WHWK $21,596,000.00
- APYX $46,512,000.00
- Revenue This Year
- WHWK N/A
- APYX $6.03
- Revenue Next Year
- WHWK N/A
- APYX $4.96
- P/E Ratio
- WHWK N/A
- APYX N/A
- Revenue Growth
- WHWK N/A
- APYX N/A
- 52 Week Low
- WHWK $1.39
- APYX $0.76
- 52 Week High
- WHWK $3.81
- APYX $2.73
- Technical
- Relative Strength Index (RSI)
- WHWK 55.63
- APYX 46.03
- Support Level
- WHWK $1.76
- APYX $1.82
- Resistance Level
- WHWK $1.87
- APYX $2.05
- Average True Range (ATR)
- WHWK 0.07
- APYX 0.13
- MACD
- WHWK 0.02
- APYX -0.01
- Stochastic Oscillator
- WHWK 83.33
- APYX 36.94
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.